The Oh Happy Day Class - Digital Connections (OHDC-DC): A Pilot Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Wisconsin, Madison
About this trial
The goal of this clinical trial is to see if a mobile phone app can deliver depression treatment to African Americans who are depressed. The main question it aims to answer is if this treatment is effective in reducing symptoms of depression.
Participants will attend six 90-minute weekly classes via an app on their phone, and will be asked to complete surveys every week. Participants can expect to be in the study for four months.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
African-American
Age 18 and older
Experiencing depression (as evidenced by a score of 5 or higher on the PHQ-9)
Own a mobile phone
Disqualifiers
Individuals who are currently receiving psychotherapy
Individuals who are presently experiencing suicidal ideation
Individuals who started psychotropic medication less than three months prior to the start of the OHDC will be excluded from the study
Participants scoring 25 or higher on the PHQ-9 will be screened out
Trial design
Design model
Single group
Treatments tested in this trial
OHDC-DC
Behavioral90-minute-weekly cognitive behavioral psycho-education classes using a mobile phone app over a 6-week period
Treatment groups
8 Participants
are divided into 1 treatment groupGroup A: Oh Happy Day Class-Digital Connections (OHDC-DC)Experimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Change in Personal Health Questionnaire Depression Scale score
Using the 8 item Personal Health Questionnaire Depression Scale (PHQ-8), participants will rate how much they have been bothered by symptoms on a scale of 0-3 with a possible range of 0 to 24. Higher scores indicate greater degree of depression.
Time frame
Baseline to one month post-intervention (approximately 12 weeks)2
Change in Generalized Anxiety Disorder 7-item (GAD-7) score
Using the GAD-7 score, participants will rate how much they have been bothered by symptoms on a scale of 0-3 with a possible range of 0 to 24. Higher scores indicate greater degree of anxiety.
Time frame
Baseline to one month post-intervention (approximately 12 weeks)3
Change in Quick Inventory of Depressive Symptomatology (QIDS)
Using the 16-item QIDS, participants will rate how much they have been bothered by symptoms on a scale of 0-3 with a possible range of 0 to 27. Higher scores indicate greater degree of depression.
Time frame
Baseline to one month post-intervention (approximately 12 weeks)4
Satisfaction with intervention
Participants will rate their satisfaction with the intervention by answering a 9-item questionnaire with a scale of 1-7 (1= none of the time, 7= all of the time). Higher scores indicate greater satisfaction with the intervention.
Time frame
12 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov